AMED:F:F-Amundi Index Solutions - Amundi ETF MSCI EMU ESG Leaders Select (EUR)

ETF | Others |

Last Closing

USD 298.1

Change

+1.95 (+0.66)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-09 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.21 (-0.75%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.35 (-0.67%)

USD 116.19B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 109.51B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.46 (-0.81%)

USD 98.97B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 63.27B
SXRZ:F iShares VII PLC - iShares Nikk..

-2.00 (-0.82%)

USD 52.42B
VUSA:F Vanguard Funds Public Limited ..

+0.05 (+0.05%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.29 (+0.26%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

+0.02 (+0.32%)

USD 38.52B
0ZC:F Zscaler Inc

-0.36 (-0.20%)

USD 37.92B

ETFs Containing AMED:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.57% 72% C 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.57% 72% C 60% D-
Trailing 12 Months  
Capital Gain 9.76% 52% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.76% 48% F 50% F
Trailing 5 Years  
Capital Gain 33.20% 64% D 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 33.20% 63% D 47% F
Average Annual (5 Year Horizon)  
Capital Gain 11.35% 73% C 68% D+
Dividend Return 11.35% 71% C- 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.82% 43% F 80% B-
Risk Adjusted Return 76.59% 78% C+ 84% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.